中文 | EN
Top search:
Home > Product
Recombinant 2019-nCoV S1 Protein(Cat. No.:DRA35)
DS
COA
Price:
Size:
50μg
500μg
1mg
Count:
-
1
+
Description
Recombinant SARS-CoV-2 S1 Protein is produced by our Mammalian expression system and the target gene encoding Gln14-Arg685 is expressed.
Accession
QHD43416.1
Known As
S1 protein; 2019-nCoV S1 protein; coronavirus S1 Protein; cov S1 Protein
Mol Mass
78.3kDa
APMol Mass
100-130kDa, reducing conditions
Formulation Description
Supplied as a 0.2 μm filtered solution of PBS, pH 7.4
Purity-SDS-PAGE
Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Bioactivity Data
1
Storage
  • Reconstituted protein solution should be stored at ≤ -20°C.
  • Stable for at least 24 months when stored as instructed.
Shipping
The product is shipped on dry ice pack.Upon receipt, store it immediately at the temperature listed below.
Background
The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
仅供科研或生产使用,不可直接应用于人体。
Novoprotein是苏州近岸蛋白质科技股份有限公司的注册商标。请访问我们的注册商标页面。
其他商标是其他所有者的财产。
Procurement Information
New Activity